Latest news for Livechain (OTC:LICH) Stock

Livechain Inc operates as a Shell company.

Livechain Inc

Lichen China Limited - Class A Ordinary Shares

Lichen China Ltd

Grant Cardone is fired up about inflation and he's not holding back. In a recent post on X (formerly Twitter), the entrepreneur laid it out in blunt terms: "Print &amp; distribute money to stupid people who then spend it on stupid stuff they otherwise could not afford." According to him, this is exactly what's happening in the current economic climate.&nbsp;
Don't Miss:
<ul>
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
<li>Founder of Personal Capital and ex-CEO of PayPal<a href="https://www.benzinga.com/money/evergreen-money"> re-engineers traditional banking with this new high-yield account — start saving better today.</a></li>
<li>This billion-dollar fund has invested in the next big real estate boom,<a href="https://www.benzinga.com/money/fundrise-flagship-fund"> here's how you can join for $10.</a></li>
</ul>
Cardone's frustration is clear. He believes the government is setting people up for failure by printing more money and not teaching financial literacy. "Until our gov't educates our citizens on financial literacy &amp; quits bailing them out, there will be slaves forever," he wrote. It's a harsh critique, but Cardone isn't known for mincing words.
He's also not shy about calling out the current administration. In a breakdown of inflation by administration, Cardone<a href="https://www.benzinga.com/real-estate/24/09/40818098/grant-cardones-inflation-breakdown-40-energy-cost-hike-marks-biden-harris-economic-impact"> highlighted a 40.2% increase in energy costs under President Joe Biden,</a> compared to a negative 0.7% during Donald Trump's term. To Cardone, this spike in energy prices is just one example of how the Biden-Harris policies are hurting the middle class. "You want more of this insanity?" he asked his followers in a previous post. "Harris will destroy the middle class."
Trending: Can you guess how many retire with a $5,000,000 nest egg? &#8211;<a href="https://www.benzinga.com/money/retire-5mil-nest-egg"> How does it compare to the average?</a>
Cardone's post didn't just throw numbers out there without context. He pointed to the Biden administration's focus on transitioning to renewable energy and stricter fossil fuel regulations as key drivers behind the rising energy costs. While he's all for innovation, Cardone argues that the policies are creating unnecessary financial burdens for everyday Americans.
But not everyone agrees with Cardone's take. Some of his followers questioned the accuracy of the data he posted. One user, "Biden's Debt Monster," pointed out that the numbers need more context, especially considering Trump's term ended during the pandemic. Another follower, Grant Goode, went even further, calling Cardone's post "deceptive" and arguing that Trump's massive spending contributed to the current economic situation.
Trending: During market downturns, investors are learning that unlike equities, these<a href="https://www.benzinga.com/money/connect-invest-real-estate-notes"> high-yield real estate notes that pay 7.5% &#8211; 9% are protected by resilient assets, buffering against losses.</a>
Cardone's response? Silence on the critique but continuing his push for financial education. To him, the real issue is deeper than just numbers. It's about how <a href="https://www.benzinga.com/personal-finance/24/08/40554281/the-razzle-dazzle-is-a-sham-grant-cardone-says-he-grew-up-in-the-democratic-party-but-now-sees-t">people are being set up to fail financially</a>. He's adamant that until Americans learn how to manage their money better – and stop relying on government handouts – things won't improve.
Cardone's blunt message is clear: Inflation isn't just a political issue; it's a personal one. And if people don't get smart about their money, they'll keep falling into the same traps.
Read Next:
<ul>
<li>The number of ‘401(k)' Millionaires is up 43% from last year —<a href="https://www.benzinga.com/money/401k-millionaires"> Here are three ways to join the club.</a></li>
<li><a href="https://www.benzinga.com/money/charlie-munger-100k">Charlie Munger said if you want to be rich, &#8220;find a way to get your hands on $100,000&#8221; — here&#8217;s what he means.</a></li>
</ul>

Personal Finance

Grant Cardone Slams Inflation: 'Print & Distribute Money To Stupid People Who Spend It On Stupid Stuff'

Goldman Sachs analyst Duffy Fischer maintains Tronox Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TROX#NYSE">TROX</a>) with a Buy and lowers the price target from $18 to $16.

News

Price Target

Analyst Ratings

TROX

Goldman Sachs Maintains Buy on Tronox Holdings, Lowers Price Target to $16

WIIM

Trump Media & Technology Group shares are trading lower, possibly amid the expiration of the lockup period that prevents large shareholders, such as Donald Trump, from selling stocks. Also, 2024 Presidential polls show that Donald Trump is behind rival candidate, Vice President Harris.

Cracker Barrel Old Country Store, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBRL#NASDAQ">CBRL</a>) reported fourth-quarter adjusted earnings per share of 98 cents, <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/n40936522/cracker-barrel-reports-fourth-quarter-fiscal-2024-results" rel="noreferrer noopener">missing the street view of $1.10. </a>Quarterly sales of $894.39 million (+6.9%), missing the analyst consensus of $897.22 million.
For the fourth quarter of fiscal 2024, total revenue includes a $62.8 million boost from the 53rd week.
Cracker Barrel&#8217;s comparable store restaurant sales rose by 0.4%, driven by total menu price increases of 4.2%.
However, comparable store retail sales fell by 4.2% compared to the same quarter last year.
Adjusted EBITDA&nbsp;was&nbsp;$57.4 million, or&nbsp;6.4%&nbsp;of total revenue versus $70.4 million, or&nbsp;8.4%&nbsp;of total revenue in the same period a year earlier.
The company announced that it has approved a quarterly dividend of $0.25 per share on its common stock. This dividend will be payable on November 13 to shareholders recorded as of October 18.
Outlook: Cracker Barrel projects FY25 total revenue between $3.4 billion and $3.5 billion, <a href="https://www.benzinga.com/calendars/guidance">compared to the $3.474 billion estimate.</a>
Cracker Barrel plans to open two new stores and three to four new Maple Street Biscuit Company units.
The company anticipates commodity inflation of 2% to 3% and hourly wage inflation of 3% to 4% compared to the previous year. It projects adjusted EBITDA between $200 million and $215 million, with capital expenditures ranging from $160 million to $180 million.
Price Action: CBRL shares are trading lower by 0.67% to $41.28 at last check Thursday.
Now Read This:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/09/40937841/jim-cramer-this-utilities-stock-is-a-buy-calls-wells-fargo-a-winner" target="_blank" rel="noreferrer noopener">Jim Cramer: This Utilities Stock Is A Buy, Calls Wells Fargo A &#8216;Winner&#8217;</a></li>
</ul>

Earnings

Equities

Guidance

Markets

General

CBRL

Cracker Barrel Battles Inflation, Eyes Expansion Amid Q4 Earnings Miss

Rumors

Trading Ideas

BNTX

Watching BioNTech; Traders Circulating Stock Picked By Popular Retail Trading Newsletter

Goldman Sachs analyst John Mackay maintains Targa Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRGP#NYSE">TRGP</a>) with a Buy and raises the price target from $147 to $163.

TRGP

Goldman Sachs Maintains Buy on Targa Resources, Raises Price Target to $163

Endava PLC&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dava#NYSE">DAVA</a>) came out with quarterly earnings of $0.28 per share, missing the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.71 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -3.45%. A quarter ago, it was expected that this company would post earnings of $0.23 per share when it actually produced earnings of $0.28, delivering a surprise of 21.74%.
Over the last four quarters, the company has surpassed consensus EPS estimates two times.
Endava, which belongs to the Zacks Computers - IT Services industry, posted revenues of $245.3 million for the quarter ended June 2024, missing the Zacks Consensus Estimate by 1.35%. This compares to year-ago revenues of $237.56 million. The company has topped consensus revenue estimates two times over the last four quarters.
The sustainability of the stock&#39;s immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management&#39;s commentary on the earnings call.
Endava shares have lost about 62.9% since the beginning of the year versus the S&amp;P 500&#39;s gain of 17.8%.
<h2>What&#39;s Next for Endava?</h2>
While Endava has underperformed the market so far this year, the question that comes to investors&#39; minds is: what&#39;s next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company&#39;s earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Endava: mixed. While the magnitude and direction of estimate revisions could change following the company&#39;s just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future.
It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $0.38 on $257.42 million in revenues for the coming quarter and $1.60 on $1.06 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Computers - IT Services is currently in the top 20% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Accenture (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/acn#NYSE">ACN</a>), another stock in the same industry, has yet to report results for the quarter ended August 2024. The results are expected to be released on September 26.
This consulting company is expected to post quarterly earnings of $2.77 per share in its upcoming report, which represents a year-over-year change of +2.2%. The consensus EPS estimate for the quarter has been revised 0% higher over the last 30 days to the current level.
Accenture&#39;s revenues are expected to be $16.33 billion, up 2.2% from the year-ago quarter.
<a href="https://www.zacks.com/stock/news/2338368/endava-plc-sponsored-adr-dava-misses-q4-earnings-and-revenue-estimates?cid=CS-BENZ-FT-tale_of_the_tape|yseop_template_4-2338368">To read this article on Zacks.com click here.</a>

Earnings Misses

Large Cap

Small Cap

Tech

DAVA

Endava PLC Misses Q4 Earnings and Revenue Estimates

Goldman Sachs analyst Ati Modak maintains MYR Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYRG#NASDAQ">MYRG</a>) with a Buy and lowers the price target from $182 to $124.

MYRG

Goldman Sachs Maintains Buy on MYR Group, Lowers Price Target to $124

California Hospital Receives Robot Upgrade
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.knightscope.com%2F&amp;esheet=54124704&amp;newsitemid=20240919470351&amp;lan=en-US&amp;anchor=Knightscope%2C+Inc.&amp;index=1&amp;md5=ead5fafeedc285e9b59834e8c11d0b13">Knightscope, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KSCP#NASDAQ">KSCP</a>) ("Knightscope" or the "Company"), an innovator in robotics and artificial intelligence ("AI") technologies focused on public safety, today announces another security robot contract renewal in Texas and a robot upgrade for a California hospital.
 &nbsp;

KSCP

Knightscope Announces Another Security Robot Contract Renewal In Texas And A Robot Upgrade For A California Hospital

Goldman Sachs analyst Caitlin Burrows maintains Macerich (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>) with a Sell and raises the price target from $13 to $14.6.

Goldman Sachs Maintains Sell on Macerich, Raises Price Target to $14.6

Goldman Sachs analyst Mike Burton maintains Cinemark Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNK#NYSE">CNK</a>) with a Sell and raises the price target from $16 to $20.

Goldman Sachs Maintains Sell on Cinemark Hldgs, Raises Price Target to $20

CNBC Halftime Report Final Trades: Target, The Home Depot, iShares Core S&P Small-Cap ETF

ABNB

RYAAY

Shares of travel and hotel-related stocks are trading higher following Wednesday's Fed rate cut. Lower rates could stimulate growth and boost consumer spending.

Live On CNBC, Kevin Simpson Announces Bought More Freeport-McMoRan

TSLA

Tesla shares are trading higher amid overall market strength following Wednesday's Fed rate cut.

Wall Street is in full risk-on mode following the Federal Reserve&#8217;s landmark decision to slash interest rates by 50 basis points, signaling further cuts as inflation approaches <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40938732/wall-street-ramps-up-interest-rate-cut-bets-after-fed-meeting-the-hard-landing-crow">the central bank&#8217;s target.</a>
The S&amp;P 500 and Dow Jones both set fresh record highs during the morning session in New York, buoyed by strong performances from the Magnificent Seven tech giants.
By midday, these elite tech stocks added over $500 billion in market value, boosting their combined market capitalization to $15.9 trillion.
Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) led the rally, surging nearly 7% and hitting a two-month peak, while NVIDIA Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) climbed 5%, driving the semiconductor sector higher.
The iShares Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOXX#NASDAQ">SOXX</a>) jumped 4.6%, fully erasing its losses from September.
The Nasdaq 100 rose 2.9%, on pace for its strongest session in over a month and outperforming other major indices. Small caps joined the rally, with the Russell 2000 index surging 2%.
Commodities rallied across the board: Gold, silver, and copper increased by 1.2%, 3.8%, and 1.8%, respectively. Oil prices, tracked by the United States Oil Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USO#NYSE">USO</a>), spiked over 3%.
The bullish sentiment extended to cryptocurrencies, with Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) rising over 2%, poised to close at its highest level since late August.
<h1 class="wp-block-heading">Thursday&#8217;s Performance In Major U.S. Indices, ETFs</h1>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices </td>
<td>Price</td>
<td>1-day %chg</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>19,905.70</td>
<td>2.9%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,249.90</td>
<td>2.0%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,720.74</td>
<td>1.8%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>42,002.90</td>
<td>1.2%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 12:25 p.m. ET</figcaption></figure>
According to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent091924&amp;t=be2bearmibe3na1">Benzinga Pro</a> data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)&nbsp;was 1.8% higher to $571.52.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>)&nbsp;rose 1.2% to $421.23.</li>
<li>The tech-heavy Invesco QQQ Trust Series (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) rallied 2.8% to $484.99.</li>
<li>The iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) rose 1.9% to $223.63.</li>
<li>The Technology Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>) outperformed, up 0.2%. The Utilities Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>) lagged, down 0.9%.</li>
</ul>
<h1 class="wp-block-heading">Thursday&#8217;s Stock Movers</h1>
<ul>
<li>Darden Restaurants Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRI#NYSE">DRI</a>) soared 9%, in response to its quarterly earnings and bullish outlook for upcoming quarters. </li>
<li>Also reacting to earnings reports was FactSet Research Systems Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDS#NYSE">FDS</a>) up 5%.</li>
<li>Companies expected to report earnings after the close include FedEx Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) and Lennar Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEN#NYSE">LEN</a>).</li>
</ul>
Read Next: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40937291/bank-stocks-hit-inflection-point-after-feds-50-basis-point-cut-analyst-reveal-top-p">• Bank Stocks Hit Inflection Point After Fed&#8217;s 50 Basis Point Cut, Analyst Reveals Top Picks</a> Images was created using artificial intelligence DALL-E

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Commodities

Economics

Intraday Update

ETFs

$BTC

SPDR Dow Jones Industrial Average ETF Trust

NVDA

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

Wall Street Breaks Records, Chipmakers Rally, Tesla Hits 2-Month High As Fed Cut Drives Risk-On Mode: What's Driving Markets Thursday?

On Wednesday, Hims &amp; Hers Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) launched the Service Appreciation Initiative, offering compounded GLP-1 weight loss medications to some personnel for as <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/b40918651/hims-hers-to-offer-access-to-compounded-glp-1-injections-for-as-low-as-99month-to-u-s-military-vet" rel="noreferrer noopener">low as $99 per month</a>.
The initiative covers eligible U.S. military personnel, veterans, teachers, nurses, and first responders.
Hims &amp; Hers Health is a telehealth company known for offering compounded alternatives to popular GLP-1 weight-loss treatments. Its shares have soared&nbsp;<a target="_blank" href="https://www.benzinga.com/general/biotech/24/08/40440501/telehealth-firm-hims-hers-health-rides-high-on-demand-for-copycat-weight-loss-drugs-amid-supply-s" rel="noreferrer noopener">over 120% since August 2023</a>.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/24/09/40736321/battle-over-compounded-weight-loss-medications-sustainability-and-regulation" rel="noreferrer noopener">Battle Over Compounded Weight-Loss Medications &#8211; Sustainability and Regulation</a>
The platform has already seen success, with over 12,000 customers reporting significant weight loss—an average of 10.2 pounds with compounded GLP-1 injections and 6.3 pounds with non-GLP-1 oral medications—within four weeks of starting treatment.
The issue of obesity is particularly significant in service roles. Studies have shown that around 70% of American adults are overweight or obese, and the rates are alarmingly high among veterans, military personnel, teachers, nurses, police officers, and firefighters.
Stress, sleep disruption, and other occupational hazards contribute to these statistics, making the need for affordable weight loss solutions even more urgent.
Novo Nordisk A/S (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>)&nbsp;CEO&nbsp;Lars Fruergaard Jørgensen has defended the high U.S. prices of the company's blockbuster drugs,&nbsp;Ozempic&nbsp;and&nbsp;Wegovy, stating that these medications are reducing the economic burden of&nbsp;<a target="_blank" href="https://www.benzinga.com/general/biotech/24/08/40422798/doctors-struggle-to-secure-medicare-coverage-for-heart-patients-on-novo-nordisks-wegovy" rel="noreferrer noopener">obesity-related health issues</a>.
Earlier this year, a study revealed that Ozempic could be produced for less than $5 a month, starkly contrasting its current&nbsp;<a target="_blank" href="https://www.benzinga.com/general/biotech/24/03/37989566/how-much-does-it-cost-to-make-novo-nordisks-ozempic-shockingly-low-against-1-000-price-tag-study-" rel="noreferrer noopener">monthly price of $968.52</a>. Similarly, Wegovy is priced at <a target="_blank" href="https://www.benzinga.com/general/biotech/24/05/39042551/novo-nordisk-faces-scrutiny-over-high-prices-of-ozempic-and-wegovy-blames-us-health-system?utm_campaign=partner_feed&amp;utm_source=yahooFinance&amp;utm_medium=partner_feed&amp;utm_content=site&amp;nid=39600377" rel="noreferrer noopener">$1,349.02 per month</a>.
Senator Bernie Sanders, chair of the Health, Education, Labor and Pensions (HELP) Committee, has been vocal about the stark price differences for Ozempic and Wegovy between the U.S.&nbsp;<a target="_blank" href="https://www.benzinga.com/general/biotech/24/07/39736330/bernie-sanders-targets-high-prices-of-ozempic-and-wegovy-in-us" rel="noreferrer noopener">and other countries</a>.
Novo Nordisk CEO Lars Jorgensen is scheduled to appear before the Senate HELP Committee, led by Chairman Bernie Sanders, for a hearing next week that will focus on hearing popular drugs, Ozempic, <a target="_blank" href="https://www.benzinga.com/general/biotech/24/08/40550961/novo-nordisk-does-not-operate-as-drug-cartel-ceo-defends-us-pricing-of-ozempic-against-criticism-" rel="noreferrer noopener">and Wegovy in the U.S.</a>
Price Action: HIMS stock is up 3.49% at $16.88 at last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40927136/amazon-boosts-worker-pay-to-over-29hour-invests-2-2b-as-holiday-kicks-in" target="_blank" rel="noreferrer noopener">Amazon Boosts Worker Pay to Over $29/Hour, Invests $2.2B As Holiday Kicks In</a>.</li>
</ul>
Photo via Shutterstock

Health Care

Hims & Hers Health, Inc. Class A Common Stock

HIMS

Hims & Hers To Offer Access To Compounded Diabetes And Weight Loss Drugs For Just $99/Month To Certain Professional Personnel

FANG

Shares of oil and gas companies are trading higher amid a rise in the price of oil after the Fed cut rates, which could lift the demand outlook. Also, ongoing tension in the Middle East could increase supply

<a href="https://www.wsj.com/business/disney-to-stop-using-slack-following-hack-that-exposed-company-data-c5311caf?mod=latest_headlines" title="https://www.wsj.com/business/disney-to-stop-using-slack-following-hack-that-exposed-company-data-c5311caf?mod=latest_headlines">https://www.wsj.com/business/disney-to-stop-using-slack-following-hack-that-exposed-company-data-c5311caf?mod=latest_headlines</a>

Disney to Stop Using Slack Following Hack That Exposed Company Data, Many Disney Teams Had Already Started to Transition to 'Streamlined Enterprise-Wide Collaboration Tools'

Investors are always looking for stocks that are poised to beat at earnings season and KB Home&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kbh#NYSE">KBH</a>)&nbsp;may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.
That is because KB Home is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. After all, analysts raising estimates right before earnings &mdash; with the most up-to-date information possible &mdash; is a pretty good indicator of some favorable trends underneath the surface for KBH in this report.
In fact, the Most Accurate Estimate for KBH for the to-be-reported quarter is currently pegged higher than the broader Zacks Consensus Estimate of $2.04 per share. This suggests that analysts have very recently bumped up their estimates for KBH, giving the stock a Zacks Earnings ESP of +0.08% heading into earnings season.
<h2>KB Home Price and EPS Surprise</h2>
<div class="chart_embed">
<img alt="KB Home Price and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/2a/1726743013.png" style="height:266px; width:538px" title="" />
KB Home price-eps-surprise | KB Home Quote
</div>
<h2>Why is this Important?</h2>
A positive reading for the Zacks Earnings ESP has proven to be very powerful in producing both positive surprises, and outperforming the market. Our recent 10-year backtest shows that stocks that have a positive Earnings ESP and a Zacks Rank #3 (Hold) or better show a positive surprise nearly 70% of the time, and have returned over 28% on average in annual returns.
Given that KBH has a Zacks Rank #3 and an ESP in positive territory, investors might want to consider this stock ahead of earnings.
Clearly, recent earnings estimate revisions suggest that good things are ahead for KB Home, and that a beat might be in the cards for the upcoming report.
<a href="https://www.zacks.com/stock/news/2338358/why-kb-home-kbh-might-surprise-this-earnings-season?cid=CS-BENZ-FT-tale_of_the_tape|earnings_surprise-2338358">To read this article on Zacks.com click here.</a>

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Livechain

News

Latest news for Livechain (OTC:LICH) Stock